Psychiatric Disorder
Researchers stress need for clear, consistent standards in FDA review of psychiatric drugs
The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously developed drugs, according to data in a research latter published in JAMA Network Open.
Maternal eating disorders, underweight, obesity linked to offspring psychiatric disorders
Offspring from mothers with an eating disorder history or prepregnancy BMI outside of normal weight range appeared to be at higher risk for neurodevelopmental and psychiatric disorders, according to a study published in JAMA Open Network.
‘Order matters’: Alopecia diagnoses precede onset of psychiatric, autoimmune comorbidities
A newly published study found that an alopecia diagnosis precedes additional psychiatric and autoimmune diagnoses in affected patients.
Mental health ‘crucial’ after first-time hospitalization for heart disease
Risk for psychiatric disorder or suicide attempt is particularly high in the first year following hospitalization for heart disease, and patient support is important to lower such risk, researchers reported.
Effectiveness of eptinezumab unaffected by psychiatric comorbidities in chronic migraine
DENVER — For those experiencing chronic migraine, the presence of self-reported psychiatric conditions did not affect the effectiveness of eptinezumab, according to a poster at the American Academy of Neurology annual meeting.
Antipsychotics may prevent relapse in first-episode psychosis with cannabis use disorder
Some antipsychotics other than olanzapine lowered the risk for hospitalization due to psychotic relapse among individuals with first-episode psychosis and co-occurring cannabis use disorder, according to a study in Schizophrenia Bulletin.
Increased suicidal behavior risk for women with perinatal depression history
Women with clinically diagnosed perinatal depression have an increased risk for suicidal behavior, especially within the first year after diagnosis, according to findings published in JAMA Network Open.
Survey: Halting neurodegeneration chief concern in Huntington’s disease
According to results of a recent survey, more than 80% of U.S.-based neurologists agreed that a major unmet need in confronting Huntington’s disease is halting neurodegeneration prior to the onset of symptoms.
Partnership to advance development of psychedelics for depression, anxiety
A clinical-stage biopharmaceutical company and a global contract research organization have partnered to support the ongoing development of investigational, psychedelic therapeutics to treat a range of psychiatric disorders.
Post-acne scarring should be treated as primary skin condition
Post-acne scarring should be treated as a distinct condition from acne vulgaris and deserves a comprehensive and unique clinical approach, according to a study.